In these studies, significant protection against experimental vaginal candidiasis after a subcutaneous immunization with Candida albicans extract was achieved in BALB/c mice but not in C57BL/ 6 (B6) mice. Protection from vaginal candidiasis was transferred to naive BALB/c mice by a population of spleen cells derived from immunized BALB/c mice. Removal of CD3 or CD4 but not CD8 T cells before transfer completely abrogated resistance to vaginal candidiasis. Recombinant inbred (RI) strains of mice derived from BALB/c and B6 strains were used for mapping loci that might be responsible for regulating vaginal protection after subcutaneous immunization. Linkage analysis using microsatellite-based genome mapping in these RI strains revealed four candidate loci on chromosomes 3, 7, 8, and 18 that exhibit statistically significant linkage to the strain distribution pattern. These results may contribute to the understanding of host genetic factors controlling the immune response to vaginal infections.
The increase in sexually transmitted diseases and other vagilated that this syndrome is the result of a down-regulation of the cell-mediated immune response, which leaves the person nal infections throughout the world has increased the interest in generating vaginal immunity against an array of organisms, susceptible to infection [11] . However, studies have shown that there is no statistical difference in either in vivo delayed-type such as Candida albicans [1, 2] , Trichomonas vaginalis [3] , herpes simplex virus [4] , and Chlamydia trachomatis [5] , which hypersensitivity or in vitro peripheral blood lymphocyte T cell responses and humoral immunity between women with recurcan have dire pathogenic consequences. In addition to introduction of pathogens from exogenous sources such as sex partners, rent vulvovaginal candidiasis and asymptomatic women [1, 12] . Thus, the relationship between peripheral immunity and some vaginal infections such as candidiasis can occur when the organisms switch from the commensal to pathogenic state vaginal immunity with respect to recurrent vulvovaginal candidiasis patients remains unclear. The role and importance of T [6] . The immune cellular composition of the vaginal mucosa, as well as other mucosal surfaces, appears to be distinct and cells in preventing murine candidiasis has been demonstrated in resistance to oral and gut mucosal infections as well as unique from that of other organs [7] . For example, previous work has shown that vaginal T cells expressing a g/d T cell systemic infections [13 -15] . However, until recently, few studies have been done to determine the basis for immunity to receptor have several features that distinguish them from this subpopulation of T cells present in other tissues [8] . The role vaginal candidiasis.
To facilitate the immunologic studies related to vaginal canof the various sets of immune cells in protecting the vaginal didiasis, an estrogen-dependent murine model has been used mucosa from colonization by pathogenic organisms remains [2] . With this murine model, previous work demonstrated that unknown or at best controversial.
subcutaneous immunization that produces an effective systemic C. albicans is a normal component of the vaginal flora of a cell-mediated immunity does not correlate with protection moderate number of women; this organism can cause opportuagainst vaginal candidiasis in all strains of mice tested [16] . nistic infections presenting commonly either as episodic infecHowever, experimental data related to vaginal infections tions or, in some persons, as recurrent vulvovaginal candidiasis.
caused by the protozoan T. vaginalis indicates that subcutaneRecurrent vulvovaginal candidiasis is a mucosal infection [6] ous immunization of BALB/c mice with this organism does affecting Ç5% of the female population who are otherwise generate a protective immune response against a vaginal infechealthy [9] . C. albicans is the pathogen in ú85% of persons tion with T. vaginalis [3] . It has recently been suggested that with recurrent vulvovaginal candidiasis [10] . It has been postuthe response to infection and immunization protection could be associated with the route of immunization [5] , resulting in organ-specific immune responses [3, 4] . Despite these facts, immunization. Furthermore, genetic studies using recombinant inbred (RI) strains of mice were done to identify candidate loci involved in controlling the immune response to vaginal candidiasis after peripheral immunization.
Materials and Methods
Mice. Female BALB/c ByJ, BALB/c J, C57BL/6 ByJ, and 12 C1B RI mice (8-10 weeks of age) were purchased from Jackson Laboratories (Bar Harbor, ME). Female BALB/c AnNCI mice were purchased from the National Cancer Institute (Bethesda, MD). The animals were housed in our animal facility colony at Allegheny University of the Health Sciences.
Organism. C. albicans B311 (ATCC 32354) was maintained at 23ЊC by weekly transfer on Sabouraud dextrose agar (SDA) plates. For all experiments, C. albicans was cultured into a fresh SDA plate 24 h before use and subsequently inoculated into 100 mL of medium (described in [17] ). After incubation for 12 h at 25ЊC under constant agitation, yeast cells were harvested by centrifugation for 10 min at 5000 g at 4ЊC and washed three times in PBS. The final pellet was resuspended in PBS at 2.5 1 10 8 cells/mL.
Antigens. Crude cytoplasmic extract of C. albicans yeast was made as previously described [18] . Briefly, C. albicans was inoculated into peptone-glucose medium, and the culture was incubated for 12 h at 25ЊC under constant agitation. The cell slurry harvested from the medium was mixed with an equal volume of glass beads and subjected to mechanical disruption in a Braun homogenizer for 8 min. Samples were examined microscopically for cell break- Figure 1 . Effects of subcutaneous immunization on primary C. alage. After beads were separated from cells, the supernatant pool bicans vaginitis in BALB/c (A) and B6 (B) mice. Mice were immuwas centrifuged at 12,000 g for 1 h at 4ЊC. The supernatant connized with 100 mg of C. albicans extract and 5 weeks later were inoculated intravaginally with 5 1 10 6 yeast cells. Weekly estrogen taining soluble cytoplasmic antigens was dialyzed and the protein treatments began 72 h before vaginal inoculation. Vaginal samples concentration determined as 9.6 mg/mL. Mice were injected subcuwere collected by lavage for 2 weeks after infection. This assay is taneously under the base of the tail with 100 mg of C. albicans representative of 3 done. Difference between unimmunized and imextract (CaX) in complete Freund's adjuvant (CFA) for immunizamunized BALB/c mice up to 10 days after infection was significant tion. The cytoplasmic extract was stored at 070ЊC until use.
( In vitro depletion of T cell subsets: adoptive cell transfer. Donor cells were derived from the spleens of BALB/c mice, which four times with the same 0.05 mL and always done by the same operator. Vaginal washes were collected every 3 days after infecwere subcutaneously immunized with 100 mg of CaX 5 weeks before transfer. Depletion of the donor splenic lymphocyte population for data shown in figures 1 and 2 and on day 6 after infection for the adoptive transfer and genetic studies. A time course study tion was done by treatment of spleen cells with antibody and complement followed by two extra rounds of depletion. Depletion demonstrated that days 3-6 after vaginal inoculation were the best in which to observe a difference in the number of Candida colonies of T lymphocytes was done with anti-CD3 monoclonal antibody produced by YCD3 hybridoma cells. Depletion of the T cell subobtained from vaginal lavage between unimmunized and immunized mice. The vaginal lavage content of each 0.05-mL sample sets, CD4 and CD8, was done with GK1.5 and 2.43 monoclonal antibodies, respectively. Donor cells were incubated with antibody was suspended in 0.5 mL of PBS and diluted serially; 0.1 mL quantities of these serial dilutions were inoculated onto plates confor 1 h at 4ЊC, followed by addition of 10% baby rabbit complement and incubation for 1 h at 37ЊC. After the three rounds of taining prewarmed SDA supplemented with penicillin-streptomy-similar results (figure 1A), immunized BALB/c mice were significantly protected from vaginal infection compared with unimmunized mice, as determined by differences in the number of C. albicans cfu present in vaginal lavage samples (P õ .05). In contrast to previous studies [16] , these results clearly demonstrate that peripheral immunization with CaX protects BALB/c mice from a subsequent vaginal C. albicans challenge. To determine if conflicting data between this study and previous studies were the result of genetic differences in the substrains used, BALB/c J (used in the previous studies) and BALB/c AnNCI substrains were also tested for protection against vaginal infection after subcutaneous immunization. Our same level of antigen-stimulated proliferation, it appears that assessed by Student's t test. Significant differences were defined estrogen treatment, which has been demonstrated to be immuas a confidence level at which P õ .05 by a one-tailed test. Simple nosuppressive, does not affect the responsiveness of a particular regression statistics were used for the genetic linkage analysis [21] .
strain more than another. CBA/J mice were also tested for protection against vaginal candidiasis after a subcutaneous immunization with CaX in CFA. In agreement with previous Results experiments [22] , CBA/J mice were not protected against vaginal candidiasis after peripheral immunization (data not shown).
Effects of subcutaneous immunization on subsequent vaginal infection. Experiments were done to determine if a peripheral
Since the ability of peripheral immunization to protect against vaginal challenge appears to be dependent on the mouse strain route of immunization could protect BALB/c mice against a subsequent vaginal C. albicans infection. Previous studies have tested, it appeared likely that the immune response generated by peripheral immunization to protect against vaginal candidiademonstrated that vaginal inoculation of C. albicans in estrogen-treated mice results in infection characterized by invasion sis was genetically regulated.
Immune response after peripheral immunization in BALB/c of vaginal tissue [2] . Histologic examination of vaginal sections from mice used in our studies confirmed the invasive nature mice. In an attempt to understand the immunologic basis for protection against vaginal C. albicans infection after peripheral of the infection (data not shown). Mice were immunized subcutaneously with CaX in CFA and, 5 weeks later, challenged immunization, the cells involved in the immune response generated after peripheral immunization in BALB/c mice were intravaginally with viable C. albicans. Vaginal lavage was done at several time points after infection. Growth of C. albicans examined. Immunologically naive and previously immunized BALB/c mice were immunosuppressed by sublethal irradiation was compared between previously immunized mice and control unimmunized mice. In a typical experiment of three done with (550 rad) 2 days before vaginal challenge with viable C. albi-cans. This radiation treatment has been demonstrated to abrogate primary immune responses while leaving secondary immune responses intact [23, 24] . Vaginal lavage was done on subsequent days to determine fungal burden. Previously immunized BALB/c mice, which were immunosuppressed before vaginal challenge with C. albicans, showed a significant increase in their ability to clear the yeast infection compared with unimmunized mice (P õ .05 for days 3, 6, and 14 after infection; figure 2 ). Therefore, immunosuppression did not abrogate the protective effects of peripheral immunization in BALB/c mice, indicating that protection against vaginal candidiasis after peripheral immunization is mediated by a secondary immune response.
To determine if T cells play a role in protection against vaginal candidiasis after peripheral immunization, the potential T cells, respectively. Significant differences between groups: control vs. untreated, P õ .02; untreated vs. 0CD3, P õ .01; untreated vs.
We have previously shown that spleen cells derived from reactive to C. albicans antigens in a lymphocyte proliferation assay [15] , and donor cells used in this experiment also demonstrated C. albicans -specific activity (data not shown). Depleted or nondepleted spleen cells were injected intravenously (10 7 be protected against vaginal candidiasis after peripheral immunization, the ability of BALB/c mice to be protected after pecells/mouse) into unimmunized, sublethally irradiated BALB/ c mice. One week later, estrogen-treated recipient mice were ripheral immunization appears to be genetically regulated. To determine if resistance to vaginal candidiasis after subcutaneinoculated with C. albicans intravaginally, and the vaginal C. albicans burden was quantitated on day 6 after infection.
ous immunization is a dominant or recessive trait, subcutaneously immunized (BALB/c 1 C57BL/6)F 1 mice were examMice that were previously subcutaneously immunized with CaX in CFA had significantly (P õ .01) lower C. albicans ined for their ability to be protected against vaginal candidiasis. Unimmunized and immunized F 1 mice were intravaginally burden in vaginal lavage fluid than did unimmunized control mice (figure 3). Immunologically naive BALB/c mice that rechallenged with viable C. albicans as previously described, and vaginal lavage was done on day 6 after infection. Immunized F 1 ceived spleen cells from immunized BALB/c mice also had significantly (P õ .02) lower C. albicans burden in vaginal mice had a significantly (P õ .01) lower C. albicans burden than did unimmunized mice (figure 4). These results demonlavage fluids than did unimmunized control mice. Transfer of C. albicans -immune spleen cells depleted of either CD3 or strate that resistance to vaginal candidiasis after peripheral immunization is a dominant trait. CD4 T cells abrogated protection conferred by the immune cells to vaginal candidiasis (P õ .01 and P õ .02, respectively) As a first step toward identifying candidate loci involved in controlling the immune response to vaginal candidiasis after (figure 3). In contrast, depletion of CD8 T cells from C. albicans -immune spleen cells before transfer did not affect the peripheral immunization, 12 RI strains of mice derived from BALB/c and B6 (C1B RI) strains were phenotyped for their protection conferred by the immune cells. These results demonstrate an essential role of T cells and specifically CD4 T cells ability to be protected against vaginal infection with C. albicans after a peripheral immunization. Our previous experiments inin protection against vaginal candidiasis after peripheral immunization in BALB/c mice.
dicated that subcutaneously immunized BALB/c mice have an average of õ75 cfu of C. albicans in vaginal lavage fluids at Genetic analysis of the mechanisms of host resistance to vaginal candidiasis after peripheral immunization. Since the day 6 after infection, whereas B6 mice have ú100 cfu of C. albicans. Therefore, the number of colonies obtained by vaginal data described above clearly indicated that there are differences between BALB/c and B6 mice with respect to their ability to lavage at day 6 after infection determined if an RI strain was / 9d4a$$jy26 05-27-98 00:36:22 jinfa UC: J Infect the intercellular adhesion molecule-1 related sequence-1 (Icam-1 rs-1). Generations of backcross mice (BALB/c 1 C57BL/6) 1 C57BL/6 are currently being tested with these markers to confirm results in the C1B RI strains and locate with higher statistical significance the loci that control resistance to vaginal candidiasis after peripheral immunization.
Discussion
In these studies, the protective effects of subcutaneous immunization with C. albicans extract in a murine pseudoestrus model of experimental vaginal candidiasis were examined. BALB/c mice immunized subcutaneously with CaX in CFA by the subcutaneous immunization in BALB/c mice is not abrogated by immunosuppression with sublethal irradiation (550 rad), indicating that protection is mediated by a secondary BALB/c-like (resistant), and was typed as c, or B6-like (suscepimmune response. The protection from vaginal challenge after tible), and was typed as b. Simultaneously, groups of unimmuperipheral immunization in BALB/c mice is associated with a nized and subcutaneously immunized BALB/c and B6 mice CD4, but not CD8, population of T cells. were treated exactly the same way as the RI strains to serve
In contrast to the results demonstrated by the present studies, as controls. The phenotypes of the 12 C1B RI strains and previous studies had demonstrated that peripheral immunizathe strain distribution patterns obtained are shown in figure 5 .
tion of a different substrain of BALB/c mice, BALB/c J, failed Phenotyping of these 12 C1B RI strains and 90 backcross to protect against vaginal challenge [16] . To determine whether mice (susceptible, 28; resistant, 62; ratio, 1:2.2) suggested that this difference in substrains might account for the differences resistance to vaginal candidiasis after subcutaneous immunizaobserved between these 2 strains, the substrains BALB/c ByJ, tion is controlled by at least one genetic locus, but most likely two loci are involved.
The strain distribution pattern for protection against vaginal candidiasis after peripheral immunization was compared with the genotypic strain distribution patterns that exist in the Mouse Genome Database for the C1B RI strains. The C1B RI strains have been typed for ú160 simple sequence length polymorphisms that scan ú80% of the mouse genome [25, 26] . Linkage analysis for candidate chromosomal regions was done by use of simple regression statistics [21] on a Map Manager computer program. Four candidate loci exhibited statistically significant linkage (P õ .01). These loci are on chromosomes 3, 7, 8, and 18 and are linked to the strain distribution pattern with LOD (logarithm of the odds) scores of 1.6, 2.2, 1.8, and 2.1, respectively (figure 6).
The marker D3Mit86 is located on chromosome 3 at 56 centimorgans (cM) position. The marker D7Nds1 is located on chromosome 7 at 29 cM position. The markers D8Mit318 and position [25] . This marker is 1 cM apart from the gene encoding / 9d4a$$jy26 05-27-98 00:36:22 jinfa UC: J Infect BALB/c AnNCI, and BALB/c J were tested at the same time infection [29] , and the role of this arm of the immune response needs to be further studied. with the same experimental approach. The data suggest that in all substrains of BALB/c mice tested, subcutaneous immunizaTwo explanations for the observation that the ability of protection against a vaginal C. albicans infection after a subcutanetion protects against a subsequent vaginal infection with C. albicans (data not shown). This contradictory result may thereous immunization depends on the mouse strain tested can be envisaged. One explanation is that there is a unique set of T fore be the result of differences in the preparation of the cytoplasmic extract used. The CaX that was used for immunization cells present in BALB/c but not in B6 mice that expresses a receptor for a ligand expressed on vaginal endothelial cells, in the present studies was prepared from supernatant containing cytoplasmic extract from disrupted yeasts, whereas the one enabling them to migrate to the vaginal mucosa on antigen recognition. It is unknown whether all T cells, once activated, used in the previous study was from culture supernatant concentrated on a molecular weight exclusion membrane. Therehave the ability to migrate to and protect the host against ''non-self '' in all organs of the body. Several reports have fore, our cytoplasmic extract may be more antigenically heterogeneous than that used in the previous study.
demonstrated strain-dependent differences in migration of various subsets of T cells [30] . The exact mechanisms of how peripheral cell-mediated immunity is translated into mucosal immunity and protection is A second possibility is that the difference in the ability of subcutaneous immunization to protect against subsequent vaginot clearly understood. It is apparent from the results presented in these studies that CD4 T cells play a role in protection nal infections resides in strain differences that enable memory T cells to migrate to the vaginal mucosa on infection. This against vaginal candidiasis after subcutaneous immunization. This result is consistent with a previous study in which CD4 genetic difference could regulate the presence of a tissue-specific homing receptor in the vaginal mucosa of BALB/c mice lymphocytes were shown to play a significant role in resistance to mucosal candidiasis [14] . One mechanism by which CD4 that is lacking in B6 mice. When BALB/c mice are vaginally infected, T cells that can respond to the antigens may receive lymphocytes may mediate resistance is by the production of cytokines, such as interferon-g, which in turn can recruit efthe signal and migrate to the infected vaginal tissue and eliminate the pathogenic organism. Since this homing receptor may fector cells, such as macrophages and neutrophils, that may protect against mucosal candidiasis [27, 28] . Humoral immunot be functionally expressed in B6 mice, the protective T cells are unable to respond to the vaginal infection. nity may also be important in protection against C. albicans B6 mice demonstrate a higher level of innate resistance to Genetic analysis also exhibited statistically significant linkage to Mif-ps5. The protein called macrophage migration inhibvaginal candidiasis than do BALB/c mice, which are more susceptible than B6 mice to the same intravaginal inoculum (5 itory factor (MIF) is described to be a T lymphocyte product that inhibits the random migration of macrophages [39] . The 1 10 6 viable C. albicans) (figure 1). No studies have been done to examine the differences between these strains with Mif-ps5 gene contains mutations that give rise to truncated MIF-like proteins [40] . However, the possibility of a functional respect to their ability to reduce vaginal candidiasis. Resistance or susceptibility to Leishmania major in B6 or BALB/c mice,
Mif pseudogene in the mouse genome cannot be excluded [40] . It appears possible that in strains such as B6, which are not respectively, has been associated with the ability of macrophages to synthesize nitric oxide following activation with inprotected against a vaginal challenge after peripheral immunization, the Mif-ps5 pseudogene could be up-regulated, resulting terferon-g [31] . Since production of nitric oxide by macrophages has been associated with resistance to murine vaginal in impairment of macrophage ability to migrate to the site of infection. candidiasis [28] , it is possible that the difference in innate resistance to vaginal C. albicans between BALB/c and B6 mice Previous studies have demonstrated a genetic control of resistance and susceptibility in mice to systemic infections with is related to nitric oxide production. Additional studies are needed to provide a biologic basis for the genetic variation in C. albicans on intravenous inoculation [13, 41 -43] . Additionally, mouse strains congenic with respect to the mouse major innate resistance to C. albicans observed in inbred strains of mice.
histocompatibility complex, H-2, have been shown to exhibit different kinetics of responses to oral mucosal infection with RI mice are one of the most powerful tools in mammalian genetics for quick and efficient mapping of any genetic locus C. albicans and the resolution of the infection [44] . These studies also demonstrated that the direct topical application of that differs between the two progenitor strains [26, 32] . The linkage analysis using 12 C1B RI strains revealed statistically C. albicans results in the generation of different types of immune responses between BALB/c and DBA/2 mouse strains, significant correlations (P õ .01) of strain distribution pattern with two markers on chromosome 8, located 2 and 3 cM apart, since delayed-type hypersensitivity reactivity could be demonstrated in DBA/2 but not BALB/c mice. These studies, thererespectively, from the mif-ps5, and one marker on chromosome 18, located 1 cM apart from the Icam-1 rs1. In addition, other fore, support the possibility that genetic differences among mouse strains may regulate the observed differences in effecstatistically significant associations of the strain distribution pattern with markers on other chromosomes were found (P õ .01).
tiveness of protection against vaginal challenge conferred by subcutaneous immunization. Linkage analysis revealed that the gene Icam-1 rs1, which is only 1 cM apart from the marker D18Mit59, is a strong In summary, this study demonstrates that it is possible to achieve significant protection against vaginal infection with C. candidate gene (P õ .01) for controlling resistance to vaginal candidiasis after peripheral immunization. The Icam-1 rs1 gene albicans by subcutaneous immunization in BALB/c mice but not in B6 mice. Moreover, protection conferred by immunizawas defined by linkage analysis with a DNA sequence probe from the intercellular adhesion molecule 1 (ICAM-1) [33] .
tion in BALB/c mice seems to be mediated by a secondary immune response associated with a CD4 population of T cells. Despite the high degree of homology between the sequences of the ICAM-1 and the Icam-1 rs1 genes, functionality of this Our data demonstrate that the ability of BALB/c mice to generate protective immune responses to vaginal challenge with C. latter gene is unknown. ICAM-1 has been shown to play a role in arresting circulating leukocytes and recruiting them to albicans after subcutaneous immunization is genetically determined. The difference in the ability to protect different strains infected or otherwise inflamed tissue sites [34] .
Evidence for genetic polymorphisms among cell adhesion of mice from vaginal C. albicans infection may, at least in part, offer an explanation for the differences in susceptibility molecules, such as ICAM-1, has been reported [35] . Genetic polymorphisms in endothelial cell adhesion molecules have of women to vaginal infections. Furthermore, gene mapping studies in the mouse system may provide valuable tools for been suggested to be important with regard to susceptibility to multifactorial disease processes that include an inflammatory elucidating gene loci regulating vaginal immunity. component [35] . Moreover, studies have shown that other adhesion molecules, such as the mucosal addressin cell adhesion
